Colorectal cancer is the abnormal growth of cells that begins in the colon or rectum. Early diagnosis, molecular profiling and precision oncology help guide personalized treatment decisions and improve patient outcomes.
Colorectal cancer is the abnormal growth of cells that starts in the large intestine (colon) or rectum.
It is often diagnosed at later stages, increasing the risk of complications. Early screening and precision oncology can help detect cancer sooner and guide personalized treatment.
Early diagnosis and precision oncology help identify the most effective treatment approach for colorectal cancer.
Assessment of the abdomen and symptoms.
Imaging to evaluate tumour location and spread.
Direct examination of the colon and rectum.
Confirms colorectal cancer through tissue analysis.
Colectomy – Removal of all or part of the colon.
Proctectomy – Removal of all or part of the rectum.
High-energy radiation used to shrink tumours before surgery or destroy cancer cells.
Drug treatment before or after surgery to reduce recurrence.
Targets specific genetic mutations in cancer cells.
Helps the immune system identify and destroy cancer cells.
Survival depends largely on the stage at diagnosis. Earlier detection generally leads to better treatment outcomes.
| Relative Survival Rate | Stage I | Stage II | Stage III | Stage IV |
|---|---|---|---|---|
| 1-Year Survival | 87.8% | 89.9% | 86.0% | 55.1% |
| 5-Year Survival | 75.8% | 72.5% | 55.6% | 17.3% |
Discover advanced genomic profiling and molecular testing solutions to support early diagnosis, personalized treatment, and therapy selection for colorectal cancer.